AICORE LIFE SCIENCES
25 October 2019
Liege, Belgium, 24 October 2019 – 7 :30 CEST – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health today announces that it has entered into two exclusive license and supply agreements with Aicore Life Sciences for the ...

19 August 2019
New interim results confirm the findings of February this year Lactate Ring (an Intravaginal Drug-Delivery System with Sustained DL-Lactic Acid Release) is a vaginal ring matrix system consisting of a mixture of ethylene vinyl ...

4 February 2019
Interim results of the clinical trial (“proof of concept”) for the vaginal ring containing lactic acid as an active ingredient are positive. The trial started in the fourth quarter of 2018. Final results are expected in the third ...

10 May 2018
An agreement was signed between the University of Ghent and Aicore Life Sciences (ALS) for the further development of a new dosage form (vaginal ring) containing lactic acid for the treatment of (recurrent) bacterial vaginosis. The University ...

16 February 2018
A Letter of the Internet was signed between Aicore Life Sciences’ “founding” fathers (CLS-Ukraine, Aicore and Dr. PG Ruifrok) to establish the incorporation of a new pharmaceutical company registered in The Netherlands. The company ...